MacFarlane Katie 4
4 · RespireRx Pharmaceuticals Inc. · Filed Oct 2, 2020
Insider Transaction Report
Form 4
MacFarlane Katie
Director
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-09-30+5,000,000→ 5,000,000 totalExercise: $0.01Exp: 2025-09-30→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]These Common Stock Options vested upon issuance.